X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs SANOFI INDIA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD SANOFI INDIA WYETH LTD/
SANOFI INDIA
 
P/E (TTM) x 27.7 37.2 74.4% View Chart
P/BV x 5.3 7.0 76.2% View Chart
Dividend Yield % 1.3 0.5 235.6%  

Financials

 WYETH LTD   SANOFI INDIA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
SANOFI INDIA
Dec-17
WYETH LTD/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,0444,945 21.1%   
Low Rs8183,901 21.0%   
Sales per share (Unadj.) Rs298.61,081.8 27.6%  
Earnings per share (Unadj.) Rs57.2141.6 40.4%  
Cash flow per share (Unadj.) Rs58.4185.9 31.4%  
Dividends per share (Unadj.) Rs17.0033.00 51.5%  
Dividend yield (eoy) %1.80.7 244.7%  
Book value per share (Unadj.) Rs249.5868.8 28.7%  
Shares outstanding (eoy) m22.7223.03 98.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.1 76.3%   
Avg P/E ratio x16.331.2 52.1%  
P/CF ratio (eoy) x15.923.8 67.0%  
Price / Book Value ratio x3.75.1 73.3%  
Dividend payout %29.723.3 127.4%   
Avg Mkt Cap Rs m21,157101,862 20.8%   
No. of employees `0000.53.2 15.2%   
Total wages/salary Rs m4003,685 10.9%   
Avg. sales/employee Rs Th13,787.47,691.9 179.2%   
Avg. wages/employee Rs Th813.01,137.7 71.5%   
Avg. net profit/employee Rs Th2,643.31,006.5 262.6%   
INCOME DATA
Net Sales Rs m6,78324,914 27.2%  
Other income Rs m353807 43.7%   
Total revenues Rs m7,13625,721 27.7%   
Gross profit Rs m1,6175,372 30.1%  
Depreciation Rs m271,022 2.6%   
Interest Rs m611 50.0%   
Profit before tax Rs m1,9385,146 37.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6321,886 33.5%   
Profit after tax Rs m1,3013,260 39.9%  
Gross profit margin %23.821.6 110.6%  
Effective tax rate %32.636.6 89.0%   
Net profit margin %19.213.1 146.5%  
BALANCE SHEET DATA
Current assets Rs m6,98414,432 48.4%   
Current liabilities Rs m2,0566,010 34.2%   
Net working cap to sales %72.633.8 214.9%  
Current ratio x3.42.4 141.5%  
Inventory Days Days9961 163.0%  
Debtors Days Days2428 84.1%  
Net fixed assets Rs m2447,991 3.1%   
Share capital Rs m227230 98.7%   
"Free" reserves Rs m5,44119,778 27.5%   
Net worth Rs m5,66820,008 28.3%   
Long term debt Rs m250-   
Total assets Rs m7,90127,770 28.5%  
Interest coverage x353.3468.8 75.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.9 95.7%   
Return on assets %16.511.8 140.3%  
Return on equity %22.916.3 140.8%  
Return on capital %34.025.8 132.1%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m156,306 0.2%   
Fx outflow Rs m2,6775,257 50.9%   
Net fx Rs m-2,6621,049 -253.8%   
CASH FLOW
From Operations Rs m9234,351 21.2%  
From Investments Rs m317-787 -40.3%  
From Financial Activity Rs m-481-1,884 25.5%  
Net Cashflow Rs m7591,680 45.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 60.4 84.6%  
Indian inst/Mut Fund % 11.3 14.4 78.5%  
FIIs % 7.2 14.6 49.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 10.5 289.5%  
Shareholders   21,978 15,184 144.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  ABBOTT INDIA  PLETHICO PHARMA  

Compare WYETH LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 300 Points Lower; Metal and IT Stocks Witness Selling(Closing)

Share markets in India witnessed most of the selling pressure during closing hours and ended their trading session on a negative note.

Related Views on News

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, SANOFI INDIA has posted a net profit of Rs 996 m (up 35.1% YoY). Sales on the other hand came in at Rs 7 bn (up 13.8% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS